GlobeStar Therapeutics
(OTC) GSTC
GlobeStar Therapeutics Financials at a Glance
Market Cap
$124.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$888.00K
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-29.44 (Low)
Dividend
$0.00
Beta (Volatility)
-29.44 (Low)
Price
$0.00
Volume
37,788
Open
$0.00
Price
$0.00
Volume
37,788
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Estimated Earnings Date
Oct 11, 2024
Dividend
$0.00
Beta (Volatility)
-29.44 (Low)
Price
$0.00
Volume
37,788
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Estimated Earnings Date
Oct 11, 2024
GSTC News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout GlobeStar Therapeutics
Industry
Biotechnology
Sector
Health CareCEO
James C. Katzaroff
Website
globestarthera.comHeadquarters
Richland, WA 99352, US
GSTC Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
148.30%
Return on Capital
N/A
Return on Assets
0.00%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$124.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
1.24B
Volume
37.79K
Avg. Volume
10.27K
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$805.00K
EBITDA
-$587.60K
Operating Cash Flow
-$148.28K
Capital Expenditure
$4.00
Free Cash Flow
-$148.28K
Cash & ST Invst.
$41.00
Total Debt
$329.05K
GlobeStar Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$124.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
N/A
N/A
Employees
0
N/A
Net Income
-$198.00K
+84.6%
EBITDA
$357.00
-94.7%
Quarterly Fundamentals
Total Cash
$41.00
N/A
Total Debt
$329.05K
+1972.3%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$329.05K
+1972.3%
Return on Assets
0.00%
N/A
Return on Invested Capital
1.30%
N/A
Free Cash Flow
-$20.40K
+49.2%
Operating Cash Flow
-$20.40K
+49.2%